High‑performance platforms built for complex clinical trials

We deliver one of the industry’s broadest and most advanced instrumentation portfolios. Our fully integrated, multi‑platform laboratories ensure scientific flexibility, fast turnaround, and globally consistent data – giving sponsors confidence at every stage of clinical development.

platforms
Purpose‑built for regulated clinical testing

We invest in best‑in‑class analytical technologies across molecular, cellular, immunological, and chromatographic workflows. This depth and diversity of platforms allows us to tailor every method to the science – not to the limitations of equipment. The result: fit‑for‑purpose assay design, robust performance, and regulatory‑ready data.

global-lab
Designed for scalability and global consistency

Our harmonized platform architecture supports large, multicenter trials and complex advanced therapy programs. From central laboratories to specialty testing centers, your studies benefit from standardized instrumentation, validated methods, and reproducible data quality worldwide.

scientist-in-the-lab
A flexible, platform‑agnostic approach

Sponsors are never locked into a single technology. We select the optimal system based on analytical need, biological mechanism, and regulatory expectations – ensuring the best possible data for every study, every time.

Instrumentation portfolio

ligand-binding

Multiplexing, plate readers & ligand binding analysis

Advanced detection systems for high‑sensitivity biomarker, immunogenicity, and pharmacodynamic assays.

Platforms include:

  • Siemens Behring

  • Luminex® 100/200, MAGPIX®

  • MSD® QuickPlex SQ 120, S 600

  • Sciex API 4000

  • Shimadzu LC

  • BioTek, DYNEX®, EnSight™, EnVision™, SpectraMax®

Our broad portfolio of multiplex, chemiluminescent, fluorescent, and absorbance systems ensures every assay is matched with the optimal detection modality for its scientific and regulatory requirements.

Automation & high‑throughput processing

Intelligent automation reduces variability and accelerates sample throughput for large, global trials.

Platforms include:

  • Beckman Coulter Biomek i7

  • Formulatrix MANTIS®

  • GSD Thunderbolt®

  • IRIS iQ200, NOVA View® IFA reader

  • Tecan Freedom EVO®

  • DNA/RNA extraction: MagNA Pure, QIAcube, KingFisher Flex, NucliSENS easyMag®/EMAG®

Automated sample preparation, extraction, PBMC isolation, and immunoassay workflows streamline operations, enhance reproducibility, and accelerate turnaround times for high‑volume global studies.

automation-platform
cobas-detail

Clinical chemistry, hematology & immunoassay systems

Validated platforms supporting routine and specialized central lab testing.

Systems include:

  • Roche cobas® 6000/8000, cobas® Pro, cobas® 6800

  • Siemens ADVIA, BN ProSpec, Centaur® XP, Atellica® IM

  • Bio‑Rad Variant II

  • Phadia ImmunoCAP 100/250

  • Sysmex CS‑2500/5100

A harmonized central laboratory platform architecture delivers consistent, high‑quality results across large, multicenter clinical trials.

Molecular & genomic analysis

Comprehensive sequencing, PCR, and nucleic acid detection capabilities for advanced therapy programs.

Platforms include:

  • ABI 3730XL Sanger Sequencer

  • ABI 7500 Fast

  • Bio‑Rad QX200 ddPCR

  • Cepheid GeneXpert®

  • BioFire® FilmArray

  • Illumina MiSeq™, NextSeq™, NovaSeq™

  • nanoString nCounter®

  • QuantStudio™ 5 & 7 Pro

Our end‑to‑end molecular capabilities – from rapid qPCR to high‑depth next‑generation sequencing – provide the precise analytical power needed to evaluate viral vectors, genetic signatures, and biodistribution.

genomic-platform
flow-platform

Flow cytometry & cell‑based analysis

State‑of‑the‑art instrumentation for immunophenotyping, functional assays, and complex cell therapy analytics.

Platforms include:

  • BD FACSymphony™, FACS Lyric™, Canto II

  • NovoCyte Quanteon

  • Revvity Celigo

  • ELISpot: CTL ImmunoSpot® S3

High‑parameter spectral flow cytometry and advanced imaging platforms enable deep immunophenotyping and cell therapy characterization with exceptional resolution and consistency.

Instrumentation that moves clinical development forward

With unmatched scientific expertise and a broad, flexible platform suite, we deliver:

  • Better assay design: Technology matched precisely to scientific goals

  • Higher data quality: Harmonized systems reduce variability

  • Faster timelines: Automation and high‑throughput workflows

  • Regulatory confidence: Fully validated platforms across GxP environments

  • Scalable global execution: Consistent performance across international sites

confident-scientist